Scientific Sessions 2024  /  Meet the Trialists: nex-Z and BPROAD  /  Meet the Trialist: Nexiguran ziclumeran (nex-z, also known as NTLA-2001), an investigational in vivo CRISPR-based therapy for patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM): interim report of the Phase 1 study
Logo

American Heart Association

  2
  0

Final ID:

Meet the Trialist: Nexiguran ziclumeran (nex-z, also known as NTLA-2001), an investigational in vivo CRISPR-based therapy for patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM): interim report of the Phase 1 study

  • Fontana, Marianna  ( University College London , London , United Kingdom )
    • Author Disclosures:
    Marianna Fontana: DO have relevant financial relationships ; Consultant:Dr. Fontana reports consultancy/advisory boards for Alnylam, Alexion/Caelum Biosciences, Astrazeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Prothena, Pfizer, Novonordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astrazeneca, Pfizer. Salary from British Heart Foundation Intermediate Fellowship. Share options in LexeoTherapeutics and shares in Mycardium.:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Meet the Trialists: nex-Z and BPROAD

Saturday, 11/16/2024 , 03:15PM - 04:00PM

Meet the Trialist

More abstracts on this topic:
Meet the Trialist: BPROAD: Effects of Intensive Blood Pressure Control in Patients with Type 2 Diabetes

Ning Guang

More abstracts from these authors:
Stiffen Up: Evaluation of HFpEF in the Patient with Cancer

Fontana Marianna, Sarswat Nitasha, Ruberg Frederick

Impact of vutrisiran on outpatient worsening heart failure in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial

Fontana Marianna, Maurer Mathew, Gillmore Julian, Bender Shaun, Aldinc Emre, Eraly Satish, Jay Patrick, Solomon Scott

You have to be authorized to contact abstract author. Please, Login
Not Available